Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
Pegozafermin by 89Bio for Fibrosis: Likelihood of Approval
Pegozafermin is under clinical development by 89Bio and currently in Phase III for Fibrosis. According to GlobalData, Phase III drugs...
Pegozafermin by 89Bio for Liver Cirrhosis: Likelihood of Approval
Pegozafermin is under clinical development by 89Bio and currently in Phase III for Liver Cirrhosis. According to GlobalData, Phase III...
Pegozafermin by 89Bio for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
Pegozafermin is under clinical development by 89Bio and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData,...